# Proposals

**URL:** https://gov.vitadao.com/c/proposals/11.md?page=2

[Latest](https://gov.vitadao.com/latest.md) · [Categories](https://gov.vitadao.com/categories.md)

**Page:** 3

---

## [VDP-115: Ambassador Program](https://gov.vitadao.com/t/vdp-115-ambassador-program/1412)

<div class="topic-metadata">

**Author:** [@consigli3re](https://gov.vitadao.com/u/consigli3re)\
**Replies:** 0\
**Last updated:** [August 15, 2023, 8:53am UTC](https://gov.vitadao.com/t/vdp-115-ambassador-program/1412 "2023-08-15T08:53:31Z")

</div>

Summary The Ambassador Program is an initiative to activate mission-aligned people and their local communities to spread VitaDAO’s vision while also, increasing governance participation and democratisation. Team Project…

---

## [VDP-112 \[Assessment\] Cyclarity - Novel cyclodextrin molecules for multiple aging-related diseases](https://gov.vitadao.com/t/vdp-112-assessment-cyclarity-novel-cyclodextrin-molecules-for-multiple-aging-related-diseases/1390)

<div class="topic-metadata">

**Author:** [@Paolo](https://gov.vitadao.com/u/Paolo)\
**Replies:** 3\
**Last updated:** [August 7, 2023, 10:44pm UTC](https://gov.vitadao.com/t/vdp-112-assessment-cyclarity-novel-cyclodextrin-molecules-for-multiple-aging-related-diseases/1390 "2023-08-07T22:44:28Z")

</div>

One-liner: Cyclarity Therapeutics is an early stage biotechnology company developing computationally designed novel cyclodextrin drug molecules for the extraction of toxic biomolecules that accumulate with age and are im…

---

## [VDP-113 \[Governance\] - Incentive Structure Framework for IP-NFT Deals and Equity Assessments in VitaDAO](https://gov.vitadao.com/t/vdp-113-governance-incentive-structure-framework-for-ip-nft-deals-and-equity-assessments-in-vitadao/1393)

<div class="topic-metadata">

**Author:** [@gweisha](https://gov.vitadao.com/u/gweisha)\
**Replies:** 6\
**Last updated:** [August 7, 2023, 4:49pm UTC](https://gov.vitadao.com/t/vdp-113-governance-incentive-structure-framework-for-ip-nft-deals-and-equity-assessments-in-vitadao/1393 "2023-08-07T16:49:50Z")

</div>

Summary This proposal aims to outline a comprehensive incentive structure for sourcing, evaluating, and executing on IP-NFT deals and equity assessments within VitaDAO. The goal is to ensure the highest quality deal flow…

---

## [VDP-114 VitaDAO's Conference Sponsorship Proposal](https://gov.vitadao.com/t/vdp-114-vitadaos-conference-sponsorship-proposal/1395)

<div class="topic-metadata">

**Author:** [@alexdobrin](https://gov.vitadao.com/u/alexdobrin)\
**Replies:** 2\
**Last updated:** [July 31, 2023, 10:18am UTC](https://gov.vitadao.com/t/vdp-114-vitadaos-conference-sponsorship-proposal/1395 "2023-07-31T10:18:16Z")

</div>

Specification Project Lead: @Max\_Unfried , @alexdobrin Team: Awareness & SciCom WG contributors Budget: 25,000 USD Summary Since its inception VitaDAO has gained clout in the Longevity Research Community through fundi…

---

## [VDP-98 \[Funding\]: ETTA Biotechnology](https://gov.vitadao.com/t/vdp-98-funding-etta-biotechnology/1278)

<div class="topic-metadata">

**Author:** [@Paolo](https://gov.vitadao.com/u/Paolo)\
**Replies:** 7\
**Last updated:** [July 27, 2023, 1:37am UTC](https://gov.vitadao.com/t/vdp-98-funding-etta-biotechnology/1278 "2023-07-27T01:37:00Z")

</div>

One-liner: ETTA is an early-stage biotechnology company developing AI/ML-designed novel molecules for simultaneously targeting senescent cells, mTOR, and insulin signaling to extend lifespan and treat serious diseases, s…

---

## [VDP-90 \[Assessment\] MutagenTech- Somatic mutation sequencing technology](https://gov.vitadao.com/t/vdp-90-assessment-mutagentech-somatic-mutation-sequencing-technology/1213)

<div class="topic-metadata">

**Author:** [@rdspang](https://gov.vitadao.com/u/rdspang)\
**Replies:** 6\
**Last updated:** [July 25, 2023, 12:06pm UTC](https://gov.vitadao.com/t/vdp-90-assessment-mutagentech-somatic-mutation-sequencing-technology/1213 "2023-07-25T12:06:02Z")

</div>

VDP-90 \[Assessment\] MutagenTech- Somatic mutation sequencing technology Longevity Dealflow WG team Scientific and Business evaluation: 3 venture capitalists, an academic professor, and a start-up founder. Shepherd : Rya…

---

## [VDP-103 \[Funding\]: Mutation-Specific Codon Suppression for Aging and Longevity](https://gov.vitadao.com/t/vdp-103-funding-mutation-specific-codon-suppression-for-aging-and-longevity/1322)

<div class="topic-metadata">

**Author:** [@Paolo](https://gov.vitadao.com/u/Paolo)\
**Replies:** 36\
**Last updated:** [July 19, 2023, 5:29pm UTC](https://gov.vitadao.com/t/vdp-103-funding-mutation-specific-codon-suppression-for-aging-and-longevity/1322 "2023-07-19T17:29:00Z")

</div>

One liner : a first-in-class intervention from an accomplished scientist entrepreneur leveraging tRNA know-how to tackle the most frequent nonsense mutation, relevant for a wide range of diseases and longevity. Longevit…

---

## [VDP-105 \[Outreach\]: Promoting Longevity Discourse in the USA Presidential Election](https://gov.vitadao.com/t/vdp-105-outreach-promoting-longevity-discourse-in-the-usa-presidential-election/1327)

<div class="topic-metadata">

**Author:** [@bianturv](https://gov.vitadao.com/u/bianturv)\
**Replies:** 9\
**Last updated:** [July 18, 2023, 5:25pm UTC](https://gov.vitadao.com/t/vdp-105-outreach-promoting-longevity-discourse-in-the-usa-presidential-election/1327 "2023-07-18T17:25:44Z")

</div>

One-liner: Community funding for a 10,000 USD prize to incentivize public discussion of longevity during the upcoming USA presidential election. Summary In our ongoing mission to promote awareness and understanding of …

---

## [VDP-109 \[Funding\]: Web3ification of TLDR longevity research peer review service](https://gov.vitadao.com/t/vdp-109-funding-web3ification-of-tldr-longevity-research-peer-review-service/1351)

<div class="topic-metadata">

**Author:** [@timrpeterson](https://gov.vitadao.com/u/timrpeterson)\
**Replies:** 14\
**Last updated:** [July 16, 2023, 6:14pm UTC](https://gov.vitadao.com/t/vdp-109-funding-web3ification-of-tldr-longevity-research-peer-review-service/1351 "2023-07-16T18:14:38Z")

</div>

One liner: we propose development of the web3 version of TLDR (the decentralized longevity review) to support: 1. content hosting on a production-grade database 2. web3 login for payment and identity management 3. upv…

---

## [VDP-111: VITA-FAST Governance and Constitution](https://gov.vitadao.com/t/vdp-111-vita-fast-governance-and-constitution/1375)

<div class="topic-metadata">

**Author:** [@tylergolato](https://gov.vitadao.com/u/tylergolato)\
**Replies:** 19\
**Last updated:** [July 11, 2023, 1:54pm UTC](https://gov.vitadao.com/t/vdp-111-vita-fast-governance-and-constitution/1375 "2023-07-11T13:54:16Z")

</div>

VITA-FAST Governance and Constitution VITA-FAST Stakeholders Stakeholders include VITA-FAST token holders, VitaDAO, the Korolchuk lab, Newcastle University, Molecule, and any service providers, as well as any other natur…

---

## [VDP-106 \[Governance\] Proposal eligibility criteria to enter the VitaDAO deal-flow funnel](https://gov.vitadao.com/t/vdp-106-governance-proposal-eligibility-criteria-to-enter-the-vitadao-deal-flow-funnel/1343)

<div class="topic-metadata">

**Author:** [@Paolo](https://gov.vitadao.com/u/Paolo)\
**Replies:** 29\
**Last updated:** [July 6, 2023, 4:48pm UTC](https://gov.vitadao.com/t/vdp-106-governance-proposal-eligibility-criteria-to-enter-the-vitadao-deal-flow-funnel/1343 "2023-07-06T16:48:08Z")

</div>

Motivation The resources of VitaDAO and applicants are precious. Both should invest time in a proposal only if it has reasonable chances to get funded, which ultimately requires a positive vote by token holders. It is th…

---

## [VDP-110: Allocating Resources for the Next Batch of VitaDAO Longevity Fellows](https://gov.vitadao.com/t/vdp-110-allocating-resources-for-the-next-batch-of-vitadao-longevity-fellows/1371)

<div class="topic-metadata">

**Author:** [@m\_marinova](https://gov.vitadao.com/u/m_marinova)\
**Replies:** 0\
**Last updated:** [July 5, 2023, 7:24am UTC](https://gov.vitadao.com/t/vdp-110-allocating-resources-for-the-next-batch-of-vitadao-longevity-fellows/1371 "2023-07-05T07:24:02Z")

</div>

VDP-110: Allocating Resources for the Next Batch of VitaDAO Longevity Fellows Project Lead: Maria Marinova Team: Vincent Weisser, Alex Dobrin Summary We propose for VitaDAO to allocate $10,000 USD to fund the next batc…

---

## [VDP-104 \[Governance\]: Amendment to VDP-100 (Fractionalization of Newcastle-Korolchuk)](https://gov.vitadao.com/t/vdp-104-governance-amendment-to-vdp-100-fractionalization-of-newcastle-korolchuk/1326)

<div class="topic-metadata">

**Author:** [@alexdobrin](https://gov.vitadao.com/u/alexdobrin)\
**Replies:** 7\
**Last updated:** [June 30, 2023, 5:49pm UTC](https://gov.vitadao.com/t/vdp-104-governance-amendment-to-vdp-100-fractionalization-of-newcastle-korolchuk/1326 "2023-06-30T17:49:23Z")

</div>

One-liner Community vote for naming the token that will represent the first IP-NFT fractionalization. Summary In VDP-100 (Fractionalization of Newcastle-Korolchuk IP-NFT) the token name for the first IP fractionalizatio…

---

## [VDP 107 \[Governance\] - Dealflow Steward Restructuring & Network Steward Preparation](https://gov.vitadao.com/t/vdp-107-governance-dealflow-steward-restructuring-network-steward-preparation/1347)

<div class="topic-metadata">

**Author:** [@alexdobrin](https://gov.vitadao.com/u/alexdobrin)\
**Replies:** 8\
**Last updated:** [June 30, 2023, 11:01am UTC](https://gov.vitadao.com/t/vdp-107-governance-dealflow-steward-restructuring-network-steward-preparation/1347 "2023-06-30T11:01:26Z")

</div>

Summary VitaDAOs involvement with the Zuzalu pop-up mini-city experiment has opened up an opportunity to further develop our network of supporters and contributors, and upon evaluating the success of Zuzalu, we propose t…

---

## [VDP-93 \[Governance\]: Proposal to Revise Governance Workflow](https://gov.vitadao.com/t/vdp-93-governance-proposal-to-revise-governance-workflow/1307)

<div class="topic-metadata">

**Author:** [@Taliskermalt](https://gov.vitadao.com/u/Taliskermalt)\
**Replies:** 21\
**Last updated:** [June 20, 2023, 11:53am UTC](https://gov.vitadao.com/t/vdp-93-governance-proposal-to-revise-governance-workflow/1307 "2023-06-20T11:53:26Z")

</div>

Summary VitaDAO has reached a point in its growth where the size of the organisation and the volume of governance activity has made it impractical for all but the mostly full-time contributors to keep up with the volume …

---

## [VDP-102 \[Governance\]: Portfolio Management Process](https://gov.vitadao.com/t/vdp-102-governance-portfolio-management-process/1312)

<div class="topic-metadata">

**Author:** [@Paolo](https://gov.vitadao.com/u/Paolo)\
**Replies:** 13\
**Last updated:** [June 15, 2023, 12:55pm UTC](https://gov.vitadao.com/t/vdp-102-governance-portfolio-management-process/1312 "2023-06-15T12:55:13Z")

</div>

One liner A set of practical tools to manage the growing portfolio of the VitaDAO projects in an effective and efficient way, helping to execute them and to support all decision-making required. Motivation Since its fou…

---

## [VDP-99: Bridging VITA to Optimism, Arbitrum and Polygon](https://gov.vitadao.com/t/vdp-99-bridging-vita-to-optimism-arbitrum-and-polygon/1282)

<div class="topic-metadata">

**Author:** [@vincent](https://gov.vitadao.com/u/vincent)\
**Replies:** 6\
**Last updated:** [May 27, 2023, 4:49pm UTC](https://gov.vitadao.com/t/vdp-99-bridging-vita-to-optimism-arbitrum-and-polygon/1282 "2023-05-27T16:49:11Z")

</div>

One-liner: This proposal suggests prioritizing the launch of VITA on the layer2s and side chains of Arbitrum, Optimism, and Polygon Summary Following VDP-20 and given the current rise in ethereum gas prices again, I pr…

---

## [VDP-100 (Fractionalization of Newcastle-Korolchuk IP-NFT)](https://gov.vitadao.com/t/vdp-100-fractionalization-of-newcastle-korolchuk-ip-nft/1285)

<div class="topic-metadata">

**Author:** [@benji](https://gov.vitadao.com/u/benji)\
**Replies:** 21\
**Last updated:** [May 24, 2023, 3:55pm UTC](https://gov.vitadao.com/t/vdp-100-fractionalization-of-newcastle-korolchuk-ip-nft/1285 "2023-05-24T15:55:59Z")

</div>

VDP-100 (Fractionalization of Newcastle-Korolchuk IP-NFT) Fractionalizing VitaDAO’s first IP-NFT to enable community governance over the IP and involvement directly into the R&D decision-making and capital allocation pro…

---

## [VDP-101 Proposal to Establish an Operating Entity for VitaDAO](https://gov.vitadao.com/t/vdp-101-proposal-to-establish-an-operating-entity-for-vitadao/1309)

<div class="topic-metadata">

**Author:** [@Taliskermalt](https://gov.vitadao.com/u/Taliskermalt)\
**Replies:** 11\
**Last updated:** [June 2, 2023, 1:19am UTC](https://gov.vitadao.com/t/vdp-101-proposal-to-establish-an-operating-entity-for-vitadao/1309 "2023-06-02T01:19:14Z")

</div>

Summary This is a proposal for the formation of an operational company for the execution of the Coordination Working Group functions on behalf of VitaDAO - specifically execution of member services, finance, communicatio…

---

## [VDP-91: TelomEYE](https://gov.vitadao.com/t/vdp-91-telomeye/1217)

<div class="topic-metadata">

**Author:** [@Rhys](https://gov.vitadao.com/u/Rhys)\
**Replies:** 5\
**Last updated:** [May 24, 2023, 3:36am UTC](https://gov.vitadao.com/t/vdp-91-telomeye/1217 "2023-05-24T03:36:16Z")

</div>

One-liner: TelomEYE is an early-stage pre-clinical startup developing an eye drop formulation to maintain/lengthen telomeres with a view to delaying presbyopia, dry eye syndrome and other age related conditions of the ey…

---

## [VDP-94 Proposal to Reallocate VITA Tokens](https://gov.vitadao.com/t/vdp-94-proposal-to-reallocate-vita-tokens/1254)

<div class="topic-metadata">

**Author:** [@Taliskermalt](https://gov.vitadao.com/u/Taliskermalt)\
**Replies:** 3\
**Last updated:** [April 23, 2023, 8:20pm UTC](https://gov.vitadao.com/t/vdp-94-proposal-to-reallocate-vita-tokens/1254 "2023-04-23T20:20:26Z")

</div>

Summary In VDP-67 and VDP-72 further token allocations have been governed for distribution to community members over the next 4 years. Meanwhile, the original 10% offered to the community under VDP-3 has been exhausted a…

---

## [VDP-97 \[Governance\]: $VITA allocations for community & awareness contributors](https://gov.vitadao.com/t/vdp-97-governance-vita-allocations-for-community-awareness-contributors/1272)

<div class="topic-metadata">

**Author:** [@alexdobrin](https://gov.vitadao.com/u/alexdobrin)\
**Replies:** 2\
**Last updated:** [April 26, 2023, 4:32am UTC](https://gov.vitadao.com/t/vdp-97-governance-vita-allocations-for-community-awareness-contributors/1272 "2023-04-26T04:32:21Z")

</div>

One-liner: Giving long-term VITA token allocations to top contributors in the Community & Awareness Working Group Summary Proposal: Allocate 700,000 VITA tokens for 6 of the top contributors and allow up to 300,000 VITA…

---

## [VDP-80 \[Assessment\]: ImmuneAGE](https://gov.vitadao.com/t/vdp-80-assessment-immuneage/1050)

<div class="topic-metadata">

**Author:** [@Paolo](https://gov.vitadao.com/u/Paolo)\
**Replies:** 13\
**Last updated:** [April 1, 2023, 4:44pm UTC](https://gov.vitadao.com/t/vdp-80-assessment-immuneage/1050 "2023-04-01T16:44:20Z")

</div>

One liner: An early-stage therapeutic biotech funded by a serial entrepreneur in longevity, focusing on immune system rejuvenation, with a lead compound targeting the hematopoietic stem cells (HSCs) of the bone marrow …

---

## [VDP-72 Proposal to Approve the Compensation Policy for 2023](https://gov.vitadao.com/t/vdp-72-proposal-to-approve-the-compensation-policy-for-2023/994)

<div class="topic-metadata">

**Author:** [@Taliskermalt](https://gov.vitadao.com/u/Taliskermalt)\
**Replies:** 19\
**Last updated:** [February 16, 2023, 8:29am UTC](https://gov.vitadao.com/t/vdp-72-proposal-to-approve-the-compensation-policy-for-2023/994 "2023-02-16T08:29:15Z")

</div>

Summary VitaDAO has been providing compensation to contributors based around VDP-3, VDP-26.1 and using soft governance within VitaCore. While this has worked to this point, a more formal, transparent compensation policy…

---

## [VDP-63 Anticancer and pro-longevity effects of high molecular weight hyaluronic acid (from naked mole rat to human) - Vera Gorbunova](https://gov.vitadao.com/t/vdp-63-anticancer-and-pro-longevity-effects-of-high-molecular-weight-hyaluronic-acid-from-naked-mole-rat-to-human-vera-gorbunova/927)

<div class="topic-metadata">

**Author:** [@tylerstahl](https://gov.vitadao.com/u/tylerstahl)\
**Replies:** 17\
**Last updated:** [March 9, 2023, 12:51am UTC](https://gov.vitadao.com/t/vdp-63-anticancer-and-pro-longevity-effects-of-high-molecular-weight-hyaluronic-acid-from-naked-mole-rat-to-human-vera-gorbunova/927 "2023-03-09T00:51:48Z")

</div>

Longevity Dealflow team Scientific evaluation: Sebastian Brunemeier, Tim Peterson, Rhys Anderson, Koen De Lombaert Business evaluation: Sebastian Brunemeier, Tim Peterson Shepherd/Sourced by: Tyler Stahl Squad members…

---

## [VDP-87 \[Assessment\] Zoe Biosciences](https://gov.vitadao.com/t/vdp-87-assessment-zoe-biosciences/1160)

<div class="topic-metadata">

**Author:** [@Paolo](https://gov.vitadao.com/u/Paolo)\
**Replies:** 0\
**Last updated:** [February 27, 2023, 10:44pm UTC](https://gov.vitadao.com/t/vdp-87-assessment-zoe-biosciences/1160 "2023-02-27T22:44:29Z")

</div>

One liner: An early-stage therapeutic biotech with two programs each centered on targets that are well validated both for longevity and aging-related diseases. Longevity Dealflow WG Team Reviewers: 2 scientists, two bio…

---

## [VDP-81 \[Funding\]: Amplio Pharma](https://gov.vitadao.com/t/vdp-81-funding-amplio-pharma/1090)

<div class="topic-metadata">

**Author:** [@ninapatrick](https://gov.vitadao.com/u/ninapatrick)\
**Replies:** 10\
**Last updated:** [March 13, 2023, 6:15pm UTC](https://gov.vitadao.com/t/vdp-81-funding-amplio-pharma/1090 "2023-03-13T18:15:30Z")

</div>

One-liner: Amplio Pharma is a clinical phase-1-ready biotech founded by an experienced pharma team in Sweden, with an innovative formulation of methotrexate. The objective: improving this cornerstone drug’s pharmacology …

---

## [VDP-85 \[Assessment\] HDAX Therapeutics](https://gov.vitadao.com/t/vdp-85-assessment-hdax-therapeutics/1150)

<div class="topic-metadata">

**Author:** [@divyacohen](https://gov.vitadao.com/u/divyacohen)\
**Replies:** 11\
**Last updated:** [February 28, 2023, 1:45am UTC](https://gov.vitadao.com/t/vdp-85-assessment-hdax-therapeutics/1150 "2023-02-28T01:45:50Z")

</div>

One liner: HDAX is a preclinical-stage drug discovery company targeting a class of proteins implicated in neuropathies and inflammation with novel small molecules having potentially superior drug properties This proposa…

---

## [2023 VitaDAO Travel Authorization and Policy](https://gov.vitadao.com/t/2023-vitadao-travel-authorization-and-policy/1228)

<div class="topic-metadata">

**Author:** [@Taliskermalt](https://gov.vitadao.com/u/Taliskermalt)\
**Replies:** 7\
**Last updated:** [March 29, 2023, 5:41pm UTC](https://gov.vitadao.com/t/2023-vitadao-travel-authorization-and-policy/1228 "2023-03-29T17:41:32Z")

</div>

2023 VitaDAO Travel Authorization and Policy Authors: Todd White (@Taliskermalt) Summary This policy describes the policy of VitaDAO to reimburse contributors for business travel expenses including 2023 Updates to per d…

---

## [VDP-73 \[Governance\]: Fractionalization of ApoptoSENS IP-NFT](https://gov.vitadao.com/t/vdp-73-governance-fractionalization-of-apoptosens-ip-nft/1006)

<div class="topic-metadata">

**Author:** [@benji](https://gov.vitadao.com/u/benji)\
**Replies:** 39\
**Last updated:** [March 27, 2023, 4:13am UTC](https://gov.vitadao.com/t/vdp-73-governance-fractionalization-of-apoptosens-ip-nft/1006 "2023-03-27T04:13:22Z")

</div>

Perform the first fractionalization of a VitaDAO IP-NFT. Summary This is a proposal for VitaDAO to fractionalize its IP-NFTs to give VitaDAO community members the opportunity to gain IP rights represented as FAM (Fracti…

[Previous page](https://gov.vitadao.com/c/proposals/11.md?page=1)

[Next page](https://gov.vitadao.com/c/proposals/11.md?page=3)
